Healthcare Value Capital as of June 30, 2013
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 46 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| iShares Russell 2000 Index (IWM) | 14.1 | $19M | 200k | 97.00 | |
| Merck & Co (MRK) | 7.3 | $10M | 217k | 46.47 | |
| Supernus Pharmaceuticals (SUPN) | 5.5 | $7.5M | 1.2M | 6.43 | |
| Auxilium Pharmaceuticals | 5.1 | $7.1M | 425k | 16.63 | |
| Teva Pharmaceutical Industries (TEVA) | 4.8 | $6.7M | 170k | 39.20 | |
| Forest Laboratories | 4.0 | $5.6M | 135k | 41.00 | |
| SPDR S&P MidCap 400 ETF (MDY) | 3.8 | $5.3M | 25k | 210.12 | |
| AstraZeneca (AZN) | 3.7 | $5.1M | 107k | 47.32 | |
| iShares NASDAQ Biotechnology Index (IBB) | 3.1 | $4.3M | 25k | 173.88 | |
| Quest Diagnostics Incorporated (DGX) | 3.0 | $4.1M | 67k | 60.63 | |
| Spdr S&p 500 Etf (SPY) | 2.9 | $4.0M | 25k | 160.44 | |
| Accuray Incorporated (ARAY) | 2.8 | $3.9M | 678k | 5.74 | |
| Endo Pharmaceuticals | 2.7 | $3.7M | 100k | 36.79 | |
| GlaxoSmithKline | 2.6 | $3.5M | 71k | 49.96 | |
| Humana (HUM) | 2.5 | $3.4M | 40k | 84.39 | |
| Cardinal Health (CAH) | 2.4 | $3.3M | 70k | 47.21 | |
| Sanofi-Aventis SA (SNY) | 2.2 | $3.0M | 58k | 51.52 | |
| Techne Corporation | 2.0 | $2.8M | 40k | 69.08 | |
| Cornerstone Therapeutics | 1.9 | $2.6M | 321k | 8.00 | |
| Biosante Pharmaceuticals | 1.8 | $2.5M | 2.2M | 1.13 | |
| Alexion Pharmaceuticals | 1.7 | $2.3M | 25k | 92.24 | |
| Sagent Pharmaceuticals | 1.6 | $2.2M | 103k | 20.98 | |
| Orthofix International Nv Com Stk | 1.4 | $1.9M | 71k | 26.90 | |
| WellPoint | 1.3 | $1.9M | 23k | 81.85 | |
| WellCare Health Plans | 1.2 | $1.7M | 30k | 55.57 | |
| NuVasive | 1.2 | $1.6M | 66k | 24.79 | |
| Qlt | 1.2 | $1.6M | 365k | 4.39 | |
| Actavis | 1.1 | $1.6M | 13k | 126.24 | |
| Health Management Associates | 1.1 | $1.6M | 100k | 15.72 | |
| Medicines Company | 1.1 | $1.5M | 50k | 30.76 | |
| Given Imaging | 1.1 | $1.5M | 110k | 14.01 | |
| St. Jude Medical | 1.0 | $1.4M | 31k | 45.62 | |
| Spectrum Pharmaceuticals | 1.0 | $1.3M | 180k | 7.46 | |
| Pacira Pharmaceuticals (PCRX) | 0.9 | $1.3M | 45k | 29.00 | |
| CryoLife (AORT) | 0.7 | $992k | 158k | 6.27 | |
| Boston Scientific Corporation (BSX) | 0.7 | $927k | 100k | 9.27 | |
| Cytokinetics (CYTK) | 0.6 | $771k | 67k | 11.57 | |
| Vivus | 0.5 | $629k | 50k | 12.58 | |
| Express Scripts Holding | 0.5 | $617k | 10k | 61.70 | |
| Vanda Pharmaceuticals (VNDA) | 0.4 | $606k | 75k | 8.08 | |
| ACCRETIVE Health | 0.4 | $531k | 49k | 10.81 | |
| Zogenix | 0.3 | $473k | 276k | 1.71 | |
| Sunesis Pharmaceuticals | 0.3 | $432k | 83k | 5.19 | |
| Arena Pharmaceuticals | 0.3 | $385k | 50k | 7.70 | |
| ZIOPHARM Oncology | 0.1 | $211k | 100k | 2.11 | |
| Anacor Pharmaceuticals In | 0.1 | $211k | 38k | 5.59 |
